Literature DB >> 16573542

Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?

Gerd R Silberhumer1, Hubert Hetz, Susanne Rasoul-Rockenschaub, Markus Peck-Radosavljevic, Thomas Soliman, Rudolf Steininger, Ferdinand Muehlbacher, Gabriela A Berlakovich.   

Abstract

Model for end-stage liver disease (MELD) score has emerged as a useful tool in predicting mortality in patients awaiting liver transplantation. There is still, however, discussion as to whether further parameters could improve the sensitivity and specificity of the MELD score. From 1997 to 2003, 621 adult patients with end-stage liver disease were listed for orthotopic liver transplantation (OLT). Patients suffering from hepatoma were excluded from analysis (113 patients). The MELD score was investigated at the time of listing (MELD ON) and of coming off the list (MELD OFF). Patients who died while on the waiting list showed a significant increase in their MELD score during the waiting time (MELD ON: 21 +/- 7 vs. MELD OFF: 28 +/- 9) as well as a significantly higher MELD ON compared with patients who were transplanted (MELD ON: 16 +/- 5 vs. MELD OFF: 17 +/- 7) or removed from the waiting list (MELD ON: 16 +/- 6 vs. MELD OFF: 12 +/- 3). Multivariate analysis identified MELD ON, ascites and recurrent infection as independent risk factors for death on the waiting list (P < 0.01). MELD score was not identified as a predictor for the post-transplant survival rate. MELD score is a strong predictor for death on the waiting list, but refractory ascites and recurrent infection are independent risk factors, too.

Entities:  

Mesh:

Year:  2006        PMID: 16573542     DOI: 10.1111/j.1432-2277.2006.00250.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  8 in total

1.  Intraoperative portal vein blood flow predicts allograft and patient survival following liver transplantation.

Authors:  Austin L Spitzer; Andre A S Dick; Ramasamy Bakthavatsalam; Jeffrey B Halldorson; Paolo R Salvalaggio; Jorge D Reyes; James D Perkins
Journal:  HPB (Oxford)       Date:  2010-04       Impact factor: 3.647

2.  Delta MELD as a predictor of early outcome in adult-to-adult living donor liver transplantation.

Authors:  Şencan Acar; Murat Akyıldız; Ahmet Gürakar; Yaman Tokat; Murat Dayangaç
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.852

3.  Aorto-hepatic bypass in liver transplantation in the MELD-era: outcomes after supraceliac and infrarenal bypasses.

Authors:  Richard Hummel; Sabrina Irmscher; Christina Schleicher; Norbert Senninger; Jens G Brockmann; Heiner H Wolters
Journal:  Surg Today       Date:  2013-03-05       Impact factor: 2.549

4.  Increase in mortality rate of liver transplant candidates residing in specific geographic areas: analysis of UNOS data.

Authors:  D Zorzi; C Rastellini; D H Freeman; G Elias; A Duchini; L Cicalese
Journal:  Am J Transplant       Date:  2012-08       Impact factor: 8.086

Review 5.  [Liver transplantation: indications and results].

Authors:  C P Strassburg; M P Manns
Journal:  Internist (Berl)       Date:  2009-05       Impact factor: 0.743

6.  Fair is fair: We must re-allocate livers for transplant.

Authors:  Brendan Parent; Arthur L Caplan
Journal:  BMC Med Ethics       Date:  2017-04-05       Impact factor: 2.652

7.  Transferrin as a predictor of survival in cirrhosis.

Authors:  André Viveiros; Armin Finkenstedt; Benedikt Schaefer; Mattias Mandorfer; Bernhard Scheiner; Konrad Lehner; Moritz Tobiasch; Thomas Reiberger; Herbert Tilg; Michael Edlinger; Heinz Zoller
Journal:  Liver Transpl       Date:  2018-03       Impact factor: 5.799

8.  The role of the comprehensive complication index for the prediction of survival after liver transplantation.

Authors:  Quirino Lai; Fabio Melandro; Greg Nowak; Daniele Nicolini; Samuele Iesari; Elisa Fasolo; Gianluca Mennini; Antonio Romano; Federico Mocchegiani; Kevin Ackenine; Marina Polacco; Laura Marinelli; Olga Ciccarelli; Giacomo Zanus; Marco Vivarelli; Umberto Cillo; Massimo Rossi; Bo-Göran Ericzon; Jan Lerut
Journal:  Updates Surg       Date:  2020-09-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.